Pobletin, Jhon Kyrie C.

HRN: 21-93-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/20/2022
09/26/2022
IV
650mg
Q8
Pneumonia
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: